{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:07:27Z","timestamp":1784700447817,"version":"3.55.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Cardiovascular disease is increasingly recognized as a heterogeneous immunometabolic disorder shaped by inflammation, metabolic rewiring, endothelial dysfunction, mitochondrial stress, and tissue remodeling across diverse cell types. This review provides a hypothesis-generating conceptual synthesis of non-coding RNA-driven cardiovascular immunometabolic reprogramming from an inflammatory endotype-oriented perspective. Because ncRNA profiling has not yet prospectively assigned cardiovascular patient cohorts to validated inflammatory endotypes, we frame mechanism-based endotypes as complementary research constructs rather than clinically deployable diagnostic categories. We discuss how conventional disease labels, including atherosclerosis, myocardial infarction, heart failure, hypertension, and cardiomyopathy, may be cross-mapped to dominant mechanisms such as athero-inflammation, sterile ischemic injury, fibro-inflammatory remodeling, metabolic inflammation, and vascular immune-endothelial dysfunction. We summarize how microRNAs, long non-coding RNAs, circular RNAs, and extracellular vesicle-associated RNA species regulate macrophage cholesterol handling, inflammasome activation, endothelial activation, vascular smooth muscle cell plasticity, cardiomyocyte mitochondrial dysfunction, fibroblast activation, extracellular matrix remodeling, and intercellular communication, with added attention to circRNA tissue-source patterns in cardiac, immune-cell, endothelial, and vascular compartments. We also highlight their context-dependent and cell type-specific actions, which challenge simple protective-versus-pathogenic classifications. Finally, we discuss translational opportunities, including circulating and extracellular vesicle-associated non-coding RNAs as liquid biopsy candidates, RNA-based therapeutics, endotype-enriched study designs, and traditional medicine-inspired multicomponent strategies. Despite barriers related to delivery, specificity, disease stage, species conservation, analytical standardization, and validation, integrated phenotyping, multi-omics profiling, functional perturbation, and biomarker-enriched trials may advance non-coding RNAs as candidate classifiers, regulators, markers, and therapeutic targets in precision cardiovascular medicine.<\/jats:p>","DOI":"10.3389\/fcell.2026.1882071","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:56:36Z","timestamp":1784699796000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-coding RNA-driven cardiovascular immunometabolic reprogramming: from inflammatory endotypes to therapeutic opportunities"],"prefix":"10.3389","volume":"14","author":[{"given":"Yang","family":"Sheng","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University (College of Integrated Traditional Chinese and Western Medicine Clinical Medicine)","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Women\u2019s Hospital, School of Medicine, Zhejiang University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengcang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine of Traditional Chinese Medicine, Zhejiang Academy of Traditional Chinese Medicine","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.120.046672","article-title":"Stem cell pluripotency genes Klf4 and Oct4 regulate complex SMC phenotypic changes critical in late-stage atherosclerotic lesion pathogenesis","volume":"142","author":"Alencar","year":"2020","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ncrna.2023.06.002","article-title":"Non-coding RNA therapeutics in cardiovascular diseases and risk factors: systematic review","volume":"8","author":"Ardiana","year":"2023","journal-title":"Noncoding RNA Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/metabo10070279","article-title":"Regulatory T cell metabolism in atherosclerosis","volume":"10","author":"Baardman","year":"2020","journal-title":"Metabolites"},{"key":"B4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/ejhf.3139","article-title":"Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: rationale and design of the HF-REVERT trial","volume":"26","author":"Bauersachs","year":"2024","journal-title":"Eur. J. Heart Fail"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-026-04408-4","article-title":"The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial","author":"Bauersachs","year":"2026","journal-title":"Nat. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1161\/CIRCRESAHA.115.306319","article-title":"Identification and characterization of hypoxia-regulated endothelial circular RNA","volume":"117","author":"Boeckel","year":"2015","journal-title":"Circ. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/cells14070553","article-title":"Circulating non-coding RNAs as indicators of fibrosis and heart failure severity","volume":"14","author":"Boichenko","year":"2025","journal-title":"Cells"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.1174381","article-title":"MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice","volume":"324","author":"Bonauer","year":"2009","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbrc.2018.11.041","article-title":"High glucose-induced circHIPK3 downregulation mediates endothelial cell injury","volume":"507","author":"Cao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41569-024-01001-5","article-title":"Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease","volume":"21","author":"Caporali","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cmet.2009.08.015","article-title":"MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1\/2","volume":"10","author":"Chan","year":"2009","journal-title":"Cell Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/s41591-024-03169-2","article-title":"The traditional Chinese medicine qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial","volume":"30","author":"Cheang","year":"2024","journal-title":"Nat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"101910","DOI":"10.1016\/j.redox.2021.101910","article-title":"The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p\/Mfn1 axis-mediated mitochondrial dynamics","volume":"41","author":"Chen","year":"2021","journal-title":"Redox Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCRESAHA.116.310529","article-title":"Paradoxical suppression of atherosclerosis in the absence of microRNA-146a","volume":"121","author":"Cheng","year":"2017","journal-title":"Circ. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"120810","DOI":"10.1016\/j.biomaterials.2021.120810","article-title":"miR-145 micelles mitigate atherosclerosis by modulating vascular smooth muscle cell phenotype","volume":"273","author":"Chin","year":"2021","journal-title":"Biomaterials"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1007\/s11033-022-07253-z","article-title":"miR-146a contributes to atherosclerotic plaque stability by regulating the expression of TRAF6 and IRAK-1","volume":"49","author":"Chu","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature08195","article-title":"miR-145 and miR-143 regulate smooth muscle cell fate and plasticity","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.117.029015","article-title":"Hematopoietic deficiency of the long noncoding RNA MALAT1 promotes atherosclerosis and plaque inflammation","volume":"139","author":"Cremer","year":"2019","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/cvr\/cvu162","article-title":"Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury","volume":"103","author":"Daniel","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.carpath.2015.04.007","article-title":"Extracellular vesicle microRNA transfer in cardiovascular disease","volume":"24","author":"Das","year":"2015","journal-title":"Cardiovasc. Pathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/eurheartj\/ehy234","article-title":"Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?","volume":"40","author":"de Gonzalo-Calvo","year":"","journal-title":"Eur. Heart J."},{"key":"B97","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/CIRCRESAHA.116.308434","article-title":"Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury","volume":"120","author":"Viereck","year":"2017","journal-title":"Circ. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jacbts.2022.12.010","article-title":"Immunometabolism at the heart of cardiovascular disease","volume":"8","author":"DeBerge","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/ATVBAHA.113.302701","article-title":"MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice","volume":"34","author":"Du","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/cvr\/cvz203","article-title":"Non-coding RNAs in cardiovascular cell biology and atherosclerosis","volume":"115","author":"Fasolo","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","article-title":"Single-cell immune landscape of human atherosclerotic plaques","volume":"25","author":"Fernandez","year":"2019","journal-title":"Nat. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.jacc.2014.07.978","article-title":"The heterogeneity of heart failure: will enhanced phenotyping be necessary for future clinical trial success?","volume":"64","author":"Francis","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1038\/s41467-019-11777-7","article-title":"Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS\/VEGF-A axis","volume":"10","author":"Garikipati","year":"2019","journal-title":"Nat. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5950813","DOI":"10.1155\/2020\/5950813","article-title":"Conceptualization of heterogeneity of chronic diseases and atherosclerosis as a pathway to precision medicine: Endophenotype, endotype, and residual cardiovascular risk","volume":"2020","author":"Genkel","year":"2020","journal-title":"Int. J. Chronic Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41467-019-14043-y","article-title":"Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium","volume":"11","author":"Gomez","year":"2020","journal-title":"Nat. Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00281-017-0656-7","article-title":"Monocyte and macrophage immunometabolism in atherosclerosis","volume":"40","author":"Groh","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/HCO.0000000000000454","article-title":"Long noncoding RNAs in cardiovascular disease, diagnosis, and therapy","volume":"32","author":"Haemmig","year":"2017","journal-title":"Curr. Opin. Cardiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"101163","DOI":"10.1016\/j.gendis.2023.101163","article-title":"Single-cell spatial transcriptomics in cardiovascular development, disease, and medicine","volume":"11","author":"Han","year":"2023","journal-title":"Genes Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s42255-018-0004-9","article-title":"The long noncoding RNA CHROME regulates cholesterol homeostasis in primates","volume":"1","author":"Hennessy","year":"2019","journal-title":"Nat. Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1161\/CIRCULATIONAHA.113.001904","article-title":"Inhibition of microRNA-92a protects against ischemia\/reperfusion injury in a large-animal model","volume":"128","author":"Hinkel","year":"2013","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.jacc.2020.02.041","article-title":"AntimiR-21 prevents myocardial dysfunction in a pig model of ischemia\/reperfusion injury","volume":"75","author":"Hinkel","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"12429","DOI":"10.1038\/ncomms12429","article-title":"Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans","volume":"7","author":"Holdt","year":"2016","journal-title":"Nat. Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e003376","DOI":"10.1161\/JAHA.112.003376","article-title":"MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-\/- mice","volume":"1","author":"Horie","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"B39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/pharmaceutics15010155","article-title":"Extracellular non-coding RNAs in cardiovascular diseases","volume":"15","author":"Jiapaer","year":"2023","journal-title":"Pharmaceutics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1093\/eurheartj\/ehaf1116","article-title":"Macrophage-specific circular RNA circHIPK2, inflammation, and fibrosis after myocardial infarction","volume":"47","author":"Jung","year":"2026","journal-title":"Eur. Heart J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCRESAHA.117.305624","article-title":"Macrophage mitochondrial energy status regulates cholesterol efflux and is enhanced by anti-miR33 in atherosclerosis","volume":"117","author":"Karunakaran","year":"2015","journal-title":"Circ. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41590-018-0113-3","article-title":"Regulation of macrophage immunometabolism in atherosclerosis","volume":"19","author":"Koelwyn","year":"2018","journal-title":"Nat. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1007\/s11033-021-06483-x","article-title":"Treg cells in atherosclerosis","volume":"48","author":"Kuan","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/cvr\/cvab160","article-title":"mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification","volume":"118","author":"Kumari","year":"2022","journal-title":"Cardiovasc Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCRESAHA.113.300226","article-title":"Non-coding RNAs in cardiac remodeling and heart failure","volume":"113","author":"Kumarswamy","year":"2013","journal-title":"Circ. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"21789","DOI":"10.1038\/srep21789","article-title":"miR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1253\/circj.cj-21-0349","article-title":"Endotyping in heart Failure- identifying mechanistically meaningful subtypes of disease","volume":"85","author":"Liang","year":"2021","journal-title":"Circ. J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"8048691","DOI":"10.1155\/2020\/8048691","article-title":"Advances in research on the circRNA-miRNA-mRNA network in coronary heart disease treated with traditional Chinese medicine","volume":"2020","author":"Lin","year":"2020","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1283494","DOI":"10.3389\/fphar.2023.1283494","article-title":"Anti-atherosclerosis mechanisms associated with regulation of non-coding RNAs by active monomers of traditional Chinese medicine","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3390\/cells11050777","article-title":"Noncoding RNAs in cardiac hypertrophy and heart failure","volume":"11","author":"Lu","year":"2022","journal-title":"Cells"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2174\/0113892010267577231005102901","article-title":"LncRNA\/CircRNA-miRNA-mRNA axis in atherosclerotic inflammation: research progress","volume":"25","author":"Lv","year":"2024","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.hlc.2013.05.651","article-title":"MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role?","volume":"22","author":"Ma","year":"2013","journal-title":"Heart Lung Circ."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1161\/CIRCRESAHA.114.303265","article-title":"Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth","volume":"114","author":"Michalik","year":"2014","journal-title":"Circ. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"eaai9118","DOI":"10.1126\/scitranslmed.aai9118","article-title":"The long noncoding RNA wisper controls cardiac fibrosis and remodeling","volume":"9","author":"Micheletti","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1172\/JCI61716","article-title":"MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages","volume":"122","author":"Nazari-Jahantigh","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1331284","DOI":"10.3389\/fendo.2023.1331284","article-title":"Immunometabolism, extracellular vesicles and cardiac injury","volume":"14","author":"Omoto","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1093\/eurheartj\/ehx165","article-title":"Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives","volume":"39","author":"Poller","year":"2018","journal-title":"Eur. Heart J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCRESAHA.118.314415","article-title":"Specific disruption of Abca1 targeting largely mimics the effects of miR-33 knockout on macrophage cholesterol efflux and atherosclerosis","volume":"124","author":"Price","year":"2019","journal-title":"Circ. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3892\/ijmm.2020.4746","article-title":"Role of m6A RNA methylation in cardiovascular disease","volume":"46","author":"Qin","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1161\/circulationaha.120.050682","article-title":"MicroRNA-21-dependent macrophage-to-fibroblast signaling determines the cardiac response to pressure overload","volume":"143","author":"Ramanujam","year":"2021","journal-title":"Circulation"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/nejmoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/nejmoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/eurheartj\/ehz542","article-title":"Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1beta inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis","volume":"41","author":"Ridker","year":"2020","journal-title":"Eur. Heart J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e006414","DOI":"10.1161\/circheartfailure.119.006414","article-title":"Obese-inflammatory phenotypes in heart failure with preserved ejection fraction","volume":"13","author":"Sabbah","year":"2020","journal-title":"Circ. Heart Fail"},{"key":"B66","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nm.4479","article-title":"Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA","volume":"24","author":"Sallam","year":"2018","journal-title":"Nat. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/cvr\/cvab192","article-title":"Non-coding RNAs in cardiac inflammation: key drivers in the pathophysiology of heart failure","volume":"118","author":"Sansonetti","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nm.3487","article-title":"MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1","volume":"20","author":"Schober","year":"2014","journal-title":"Nat. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/164_2020_423","article-title":"Regulatory non-coding RNAs in atherosclerosis","volume":"270","author":"Schober","year":"2022","journal-title":"Handb. Exp. Pharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1093\/eurheartj\/ehac463","article-title":"Small non-coding RNA therapeutics for cardiovascular disease","volume":"43","author":"Shah","year":"2022","journal-title":"Eur. Heart J."},{"key":"B72","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.119.316461","article-title":"Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression","volume":"127","author":"Sharma","year":"2020","journal-title":"Circ. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1161\/circulationaha.121.056929","article-title":"MicroRNA-210 controls mitochondrial metabolism and protects heart function in myocardial infarction","volume":"145","author":"Song","year":"2022","journal-title":"Circulation"},{"key":"B74","doi-asserted-by":"publisher","first-page":"H1060","DOI":"10.1152\/ajpheart.00859.2016","article-title":"B cells and atherosclerosis","volume":"312","author":"Srikakulapu","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1161\/CIRCRESAHA.119.315939","article-title":"Intracellular and intercellular aspects of macrophage immunometabolism in atherosclerosis","volume":"126","author":"Tabas","year":"2020","journal-title":"Circ. Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"Taubel","year":"2021","journal-title":"Eur. Heart J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1161\/circresaha.124.323660","article-title":"Intersection of immunology and metabolism in myocardial disease","volume":"134","author":"Thorp","year":"2024","journal-title":"Circ. Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.yjmcc.2020.04.032","article-title":"Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure","volume":"143","author":"Tian","year":"2020","journal-title":"J. Mol. Cell Cardiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1038\/s41598-021-84056-5","article-title":"CircSLC8A1 and circNFIX can be used as auxiliary diagnostic markers for sudden cardiac death caused by acute ischemic heart disease","volume":"11","author":"Tian","year":"2021","journal-title":"Sci. Rep."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e326799","DOI":"10.1161\/CIRCRESAHA.125.326799","article-title":"Interleukin 11-induced microRNAs as functional mediators and circulating biomarkers of cardiac fibrosis","volume":"138","author":"Tikhomirov","year":"2026","journal-title":"Circ. Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/08830180903093796","article-title":"miR-155: on the crosstalk between inflammation and cancer","volume":"28","author":"Tili","year":"2009","journal-title":"Int. Rev. Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"van Rooij","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.jacc.2016.06.040","article-title":"Myocardial infarction-associated circular RNA predicting left ventricular dysfunction","volume":"68","author":"Vausort","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"326ra22","DOI":"10.1126\/scitranslmed.aaf1475","article-title":"Long noncoding RNA chast promotes cardiac remodeling","volume":"8","author":"Viereck","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nm.4179","article-title":"The long noncoding RNA chaer defines an epigenetic checkpoint in cardiac hypertrophy","volume":"22","author":"Wang","year":"2016","journal-title":"Nat. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41392-023-01638-7","article-title":"RNA modification in cardiovascular disease: implications for therapeutic interventions","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1337623","DOI":"10.3389\/fphar.2024.1337623","article-title":"Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1161\/ATVBAHA.112.300279","article-title":"MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?","volume":"33","author":"Wei","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.jacc.2020.12.058","article-title":"Pooled patient-level analysis of inclisiran trials in patients with elevated low-density lipoprotein cholesterol","volume":"77","author":"Wright","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00109-022-02186-3","article-title":"Circular RNAs: regulators of vascular smooth muscle cells in cardiovascular diseases","volume":"100","author":"Wu","year":"2022","journal-title":"J. Mol. Med. Berl."},{"key":"B92","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ymthe.2019.09.008","article-title":"Macrophage miR-34a is a key regulator of cholesterol efflux and atherosclerosis","volume":"28","author":"Xu","year":"2020","journal-title":"Mol. Ther."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1159\/000479995","article-title":"Mir-21 promotes cardiac fibrosis after myocardial infarction via targeting Smad7","volume":"42","author":"Yuan","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"B94","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s12265-022-10252-x","article-title":"Leveraging extracellular non-coding RNAs to diagnose and treat heart diseases","volume":"15","author":"Zhao","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1111\/jcmm.13654","article-title":"miR-21 promotes cardiac fibroblast-to-myofibroblast transformation and myocardial fibrosis by targeting Jagged1","volume":"22","author":"Zhou","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.atherosclerosis.2010.12.024","article-title":"Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration","volume":"215","author":"Zhu","year":"2011","journal-title":"Atherosclerosis"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1882071\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:56:37Z","timestamp":1784699797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1882071\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":96,"alternative-id":["10.3389\/fcell.2026.1882071"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1882071","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1882071"}}